Martin, John D. http://orcid.org/0000-0002-9828-8203
Cabral, Horacio
Stylianopoulos, Triantafyllos http://orcid.org/0000-0002-3093-1696
Jain, Rakesh K. http://orcid.org/0000-0001-7571-3548
Article History
Accepted: 25 November 2019
First Online: 7 February 2020
Competing interests
: J.D.M. became a full-time employee of NanoCarrier during the preparation of this manuscript. R.K.J. has received honoraria from Amgen, has acted as a consultant for Chugai, Merck, Ophthotech, Pfizer, SPARC, SynDevRx and XTuit, owns equity in Enlight, Ophthotech and SynDevRx and serves on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. H.C. and T.S. declare no competing interests.